Description
Pharmaceutical Zoledronic Acid CAS 118072-93-8 For Cancer Treatment
Description
| Product Name: | Zoledronic Acid | Other Name: | 2-(imidazole-1-yl)-1-acetic Acid HCl |
|---|---|---|---|
| CAS No: | 118072-93-8 | Purity: | 99% Min |
| Shelf Life: | 2 Years | Application: | Medication |
| Sample: | Available | Storage: | Cool And Dry Place |
| Appearance: | White Powder | ||
| High Light: |
Pharmaceutical Zoledronic Acid, Zoledronic Acid For Cancer Treatment, Pharmaceutical Powder CAS 118072-93-8 |
||
Pharmaceutical API High Purity Cancer Treatment Zoledronic Acid CAS 118072-93-8
Product Introduction
Name: Zoledronic acid
English Synonym: 2-(imidazole-1-yl)-1-acetic acid HCl
CAS Number: 118072-93-8
Molecular formula: C5H10N2O7P2
Molecular weight: 272.09
EINECS number: 1806241-263-5
Product Description
Melting point: 193-204°C (dec)
Boiling point: 764.0±70.0°C(Predicted)
Density: 2.13±0.1g/cm3(Predicted)
Storage conditions: Sealed in dry, Room Temperature
Acidity coefficient (pKa): 1.41±0.10 (Predicted)
Product Function
Zoledronic acid is a third-generation bisphosphonate compound and an effective inhibitor of bone resorption. The drug can inhibit osteoclast activity, induce osteoclast apoptosis, prevent the resorption of mineral bone and cartilage by binding to bone, and inhibit the increase in osteoclast activity caused by various stimulating factors released by tumor cells And bone calcium release, can effectively control hypercalcemia.
